Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 72

Sort by

Sort Order Select

Journal Articles

Highly Reduced Survival in ET and PV Patients with Vascular Complications during Follow-up - Real World Data from the Swedish MPN Registr

Marie Lindgren, Erik Ahlstrand, MD PhD, Helna Pettersson, MD, Maria Liljeholm, Anna Ravn-Landtblom, MD, Stefan Scheding, Prof, Björn Andréasson, MD PhD, Jan Samuelsson, MD PhD

Blood (2019) 134 (Supplement_1): 1658.

https://doi.org/10.1182/blood-2019-124374

Published: 2019

Journal Articles

Haploidentical Hematopoietic Stem Cell Transplantation May Improve Prognosis in Non-Infant Children with t(v;11q23)/MLL-Rearranged B-Acute Lymphoblastic Leukemia

Blood (2019) 134 (Supplement_1): 2049.

https://doi.org/10.1182/blood-2019-127704

Published: 2019

Journal Articles

Next-Generation Sequencing of HLA Loci Identifies Predisposing and Protective Factors for Immune-Mediated Thrombotic Thrombocytopenic Purpura in a Japanese Population

Kazuya Sakai, MD, Masataka Kuwana, Hiroto Kojima, Hidenori Tanaka, Masayuki Kubo, Hideo Yagi, Masanori Matsumoto

Blood (2019) 134 (Supplement_1): 1085.

https://doi.org/10.1182/blood-2019-123927

Published: 2019

Journal Articles

Racial Variation in ITP Prevalence and Rate of Chronic Disease Suggests Biological Differences

Lauryn S. Walker, Taylor Olmsted Kim, MD, Amanda Bell Grimes, MD, Susan Kirk, PA-C, Audrey S. Cohen, Abinaya Arulselvan, Scott E. Wenderfer, MD, Michele P. Lambert, MD, Jenny M. Despotovic, DO, MS

Blood (2019) 134 (Supplement_1): 387.

https://doi.org/10.1182/blood-2019-130418

Published: 2019

Journal Articles

Pre-Emptive Tyrosine Kinase-Inhibitor Intervention Based on BCR/ABL1 Monitoring in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia after Allo-HSCT: Two Independent Observational Cohort Study

Liu Hui, MD, Li Xuan, MD, Ren Lin, MD, Lan Deng, MD PhD, Fen Huang, MD, Zhiping Fan, MD, Danian Nie, MD, Xudong Li, Xinquan Liang, Dan Xu, Yu Zhang, Na Xu, MD, Jieyu Ye, MD PhD, Hua Jin, Dongjun Lin, MD, Liping MA, MD, Jing Sun, MD, Xiaojun Huang, MD, Qifa Liu, MD

Blood (2019) 134 (Supplement_1): 3303.

https://doi.org/10.1182/blood-2019-126901

Published: 2019

Journal Articles

Impact of Donor-Derived CD34+ Infused Cell Dose on Outcomes of Patients Undergoing Allo-HCT Following Reduced Intensity Regimen for Myelofibrosis:a Study from the Chronic Malignancies Working Party of the EBMT

Blood (2019) 134 (Supplement_1): 3338.

https://doi.org/10.1182/blood-2019-123827

Published: 2019

Journal Articles

Prevalence of Venous Thromboembolism in Ambulatory and Non-Ambulatory Patients with Cerebral Palsy

Michael Daunov, DO, Justin Rondinelli, MD, Sanjay P Ahuja, MD, Nathan Richard Stehouwer, MD

Blood (2019) 134 (Supplement_1): 2428.

https://doi.org/10.1182/blood-2019-130622

Published: 2019

Journal Articles

Silent Cerebral Infarcts in Sickle Cell Disease: A Systematic Review

Maite E. Houwing, MD, Rowena Grohssteiner, BSc, Anne P.J. de Pagter, MD PhD, Karin Fijnvandraat, MD PhD, Jaap Oosterlaan, Lotte Haverman, Marjolein Dremmen, Tonya White, Marjon H. Cnossen, MD PhD

Blood (2019) 134 (Supplement_1): 4836.

https://doi.org/10.1182/blood-2019-130165

Published: 2019

Journal Articles

Coenzyme Q10 Attenuates Platelet Integrin αIIbβ3 Outside-in Signaling through Targeting cAMP/PKA Pathway and Inhibits Atherosclerosis

Yan Yang, MD PhD, Xiaohong Ruby Xu, MD PhD, Heyu Ni, MD MSc, PhD, Liping Ma, MD, Wenhua Ling, Fuli Ya

Blood (2018) 132 (Supplement 1): 2423.

https://doi.org/10.1182/blood-2018-99-120196

Published: 2018

Journal Articles

Is There a Role for Thromboprophylaxis in Sickle Cell Patients with Central Venous Access Devices?

Stéphanie Forté, MD MSc, FRCPC, Nafanta Fadiga, Olivia Pestrin, John Chinawaeze Aneke, MBBS, FMCPath, Shivani Bhat, MPH, Richard Ward, MBBS, MRCP, Kevin H. M. Kuo, MD MSc, FRCPC

Blood (2018) 132 (Supplement 1): 3518.

https://doi.org/10.1182/blood-2018-99-119716

Published: 2018

Journal Articles

Carfilzomib Cardiovascular Disease: Use of the Atherosclerotic Cardiovascular Disease Score to Predict Cardiovascular Events in Multiple Myeloma Patients Treated with Carfilzomib

Ricardo Parrondo, MD, Tracy Andrews, MSc, Rima M Panchal, MD, Sejal Kothadia, MD, Camille Johnson, MD, Jieqi Liu, Giselle Alexandra Suero-Abreu, MD PhD, David H. Vesole, MD PhD, David S Siegel, MD PhD, Noa Biran, MD

Blood (2018) 132 (Supplement 1): 3254.

https://doi.org/10.1182/blood-2018-99-113722

Published: 2018

Journal Articles

Hypertension Development, Management, and Cardiovascular Events Following Ibrutinib Initiation for Hematologic Malignancies

Tyler Dickerson, PharmD, Tracy Wiczer, Allyson Waller, Jennifer Philippon, Devin Haddad, Avirup Guha, Kyle Porter, Kerry A. Rogers, MD, Jennifer A. Woyach, MD, John C. Byrd, MD, Daniel Addison, Farrukh T. Awan, MD MS

Blood (2018) 132 (Supplement 1): 4423.

https://doi.org/10.1182/blood-2018-99-110345

Published: 2018

Journal Articles

Risk Factors for Early Mortality in Hemato-Oncological Patients with Carbapenem Resistant Acinetobacter Baumannii (CRAB) Bacteremia

Liat Shargian-Alon, MD, Anat Gafter-Gvili, Ofir Wolach, MD, Moshe Yeshurun, Pia Raanani, Dafna Yahav, MD

Blood (2018) 132 (Supplement 1): 4953.

https://doi.org/10.1182/blood-2018-99-114165

Published: 2018

Journal Articles

Superior Salvage Treatment with Regimen Containing Sorafenib for Relapse of Acute Myeloid Leukemia with FLT3-ITD after Allo-HSCT

Li Xuan, Yu Wang, Jia Chen, Erlie Jiang, Li Gao, Bingyi Wu, MD, Lan Deng, MD PhD, Xinquan Liang, Fen Huang, Zhiping Fan, Xiaowen Tang, Jing Sun, Xi Zhang, Ming-Zhe Han, De-Pei Wu, Xiao Jun Huang, Qifa Liu, MD

Blood (2018) 132 (Supplement 1): 2129.

https://doi.org/10.1182/blood-2018-99-114103

Published: 2018

Journal Articles

Should Women with Sickle Cell Disease be Administered Prophylactic Transfusions to Avoid Complications during Pregnancy?

Patricia Palcu, BSc, Kevin H. M. Kuo, MDMSc, FRCPC, Richard Ward, MBBS, MRCP, Nusrat Zaffar, MD, Ann Kinga Malinowski, MD MSc, FRCSC, Nadine Shehata, MD FRCPC, MSc

Blood (2018) 132 (Supplement 1): 3679.

https://doi.org/10.1182/blood-2018-99-112133

Published: 2018

Journal Articles

Low Fixed Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Disease in Nigeria

Titilola S. Akingbola, MBBS, FWACP, Bamidele Tayo, PhD, Santosh L. Saraf, MD, Binal N. Shah, PhD, Chinedu A Ezekekwu, MBBS, Omowunmi Sonubi, MBBS, Lewis L. Hsu, MD PhD, Richard S. Cooper, MD, Victor R. Gordeuk, MD

Blood (2017) 130 (Supplement 1): 981.

https://doi.org/10.1182/blood.V130.Suppl_1.981.981

Published: 2017

Journal Articles

The First Two Years of Life in Sickle Cell Anemia Infants: Results of a Comprehensive Longitudinal Study

Blood (2017) 130 (Supplement 1): 688.

https://doi.org/10.1182/blood.V130.Suppl_1.688.688

Published: 2017

Journal Articles

A New Multi-Factor Risk Score System Depending on Gene Mutation and Overexpression for Predicting the Outcome in AML1-ETO-Positive Acute Myeloid Leukemia

Guo-Pan Yu, MD, Changxin Yin, Fuqun Wu, Dan Xu, Zhongxin Zheng, Ling Jiang, PhD MD, Fang Chen, Xuejie Jiang, MD, Qifa Liu, Fanyi Meng

Blood (2017) 130 (Supplement 1): 5088.

https://doi.org/10.1182/blood.V130.Suppl_1.5088.5088

Published: 2017

Journal Articles

Day 100 Levels of Blood Immune Cells Are Prognostic Biomarkers for Allogeneic Hematopoietic Stem Cell Transplant Outcomes: Results from BMT CTN 0201

Shanelle M. Fernando, Brent R. Logan, PhD, Mingwei Fei, MS, Stephanie J. Lee, MD PhD, Dennis Confer, MD, Alan Howard, PhD, Shanmuganathan Chandrakasan, MD, Cynthia R. Giver, PhD, Claudio Anasetti, MD, Edmund K. Waller, MD

Blood (2017) 130 (Supplement 1): 516.

https://doi.org/10.1182/blood.V130.Suppl_1.516.516

Published: 2017

Journal Articles

The Effect of Sorafenib Therapy on the Outcome of Acute Myeloid Leukemia with FLT3-ITD Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Li Xuan, Yu Wang, Fen Huang, Bingyi Wu, MD, Zhiping Fan, Na Xu, PhD, Jieyu Ye, Jing Sun, MD, Xiaojun Huang, Qifa Liu

Blood (2017) 130 (Supplement 1): 2045.

https://doi.org/10.1182/blood.V130.Suppl_1.2045.2045

Published: 2017

NARROW

Highly Reduced Survival in ET and PV Patients with Vascular Complications during Follow-up - Real World Data from the Swedish MPN Registr

Haploidentical Hematopoietic Stem Cell Transplantation May Improve Prognosis in Non-Infant Children with t(v;11q23)/MLL-Rearranged B-Acute Lymphoblastic Leukemia

Next-Generation Sequencing of HLA Loci Identifies Predisposing and Protective Factors for Immune-Mediated Thrombotic Thrombocytopenic Purpura in a Japanese Population

Racial Variation in ITP Prevalence and Rate of Chronic Disease Suggests Biological Differences

Pre-Emptive Tyrosine Kinase-Inhibitor Intervention Based on BCR/ABL1 Monitoring in Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia after Allo-HSCT: Two Independent Observational Cohort Study

Impact of Donor-Derived CD34+ Infused Cell Dose on Outcomes of Patients Undergoing Allo-HCT Following Reduced Intensity Regimen for Myelofibrosis:a Study from the Chronic Malignancies Working Party of the EBMT

Prevalence of Venous Thromboembolism in Ambulatory and Non-Ambulatory Patients with Cerebral Palsy

Silent Cerebral Infarcts in Sickle Cell Disease: A Systematic Review

Coenzyme Q10 Attenuates Platelet Integrin αIIbβ3 Outside-in Signaling through Targeting cAMP/PKA Pathway and Inhibits Atherosclerosis

Is There a Role for Thromboprophylaxis in Sickle Cell Patients with Central Venous Access Devices?

Carfilzomib Cardiovascular Disease: Use of the Atherosclerotic Cardiovascular Disease Score to Predict Cardiovascular Events in Multiple Myeloma Patients Treated with Carfilzomib

Hypertension Development, Management, and Cardiovascular Events Following Ibrutinib Initiation for Hematologic Malignancies

Risk Factors for Early Mortality in Hemato-Oncological Patients with Carbapenem Resistant Acinetobacter Baumannii (CRAB) Bacteremia

Superior Salvage Treatment with Regimen Containing Sorafenib for Relapse of Acute Myeloid Leukemia with FLT3-ITD after Allo-HSCT

Should Women with Sickle Cell Disease be Administered Prophylactic Transfusions to Avoid Complications during Pregnancy?

Low Fixed Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Disease in Nigeria

The First Two Years of Life in Sickle Cell Anemia Infants: Results of a Comprehensive Longitudinal Study

A New Multi-Factor Risk Score System Depending on Gene Mutation and Overexpression for Predicting the Outcome in AML1-ETO-Positive Acute Myeloid Leukemia

Day 100 Levels of Blood Immune Cells Are Prognostic Biomarkers for Allogeneic Hematopoietic Stem Cell Transplant Outcomes: Results from BMT CTN 0201

The Effect of Sorafenib Therapy on the Outcome of Acute Myeloid Leukemia with FLT3-ITD Undergoing Allogeneic Hematopoietic Stem Cell Transplantation

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only